Survival Outcomes Among Patients With Gastric Adenocarcinoma Who Received Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 31188418.
- Also identified by DOI 10.1001/jamasurg.2019.1698 and PMC identifier 6563585.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study assesses survival outcomes among patients with gastric adenocarcinoma who received hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery at US academic centers.
Medical subject headings
- Adenocarcinoma
- Cytoreduction Surgical Procedures
- Hyperthermia, Induced
- Stomach Neoplasms